Annual Shareholders Equity
$1.58 M
-$2.32 M-59.49%
December 31, 2023
Summary
- As of February 7, 2025, ATXI annual stockholders equity is $1.58 million, with the most recent change of -$2.32 million (-59.49%) on December 31, 2023.
- During the last 3 years, ATXI annual shareholders equity has fallen by -$777.00 thousand (-32.94%).
- ATXI annual shareholders equity is now -91.84% below its all-time high of $19.38 million, reached on December 31, 2017.
Performance
ATXI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.61 M
-$2.15 M-45.21%
September 30, 2024
Summary
- As of February 7, 2025, ATXI quarterly stockholders equity is $2.61 million, with the most recent change of -$2.15 million (-45.21%) on September 30, 2024.
- Over the past year, ATXI quarterly shareholders equity has increased by +$1.03 million (+64.98%).
- ATXI quarterly shareholders equity is now -90.39% below its all-time high of $27.16 million, reached on June 30, 2017.
Performance
ATXI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ATXI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.5% | +65.0% |
| 3 y3 years | -32.9% | -24.4% |
| 5 y5 years | +350.7% | -78.2% |
ATXI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.5% | at low | -45.2% | +148.9% |
| 5 y | 5-year | -76.7% | at low | -61.6% | +148.9% |
| alltime | all time | -91.8% | +119.2% | -90.4% | +129.3% |
Avenue Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.61 M(-45.2%) |
| Jun 2024 | - | $4.76 M(+68.0%) |
| Mar 2024 | - | $2.84 M(+79.3%) |
| Dec 2023 | $1.58 M(-59.5%) | $1.58 M(-143.3%) |
| Sep 2023 | - | -$3.65 M(-31.6%) |
| Jun 2023 | - | -$5.34 M(+267.5%) |
| Mar 2023 | - | -$1.45 M(-137.2%) |
| Dec 2022 | $3.90 M(+13.2%) | $3.90 M(<-9900.0%) |
| Sep 2022 | - | -$39.00 K(-106.5%) |
| Jun 2022 | - | $598.00 K(-48.4%) |
| Mar 2022 | - | $1.16 M(-66.4%) |
| Dec 2021 | $3.45 M(+46.3%) | $3.45 M(-2256.9%) |
| Sep 2021 | - | -$160.00 K(-124.9%) |
| Jun 2021 | - | $642.00 K(-56.5%) |
| Mar 2021 | - | $1.48 M(-37.5%) |
| Dec 2020 | $2.36 M | $2.36 M(-27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $3.23 M(-21.1%) |
| Jun 2020 | - | $4.10 M(-29.0%) |
| Mar 2020 | - | $5.77 M(-15.1%) |
| Dec 2019 | $6.80 M(-1177.7%) | $6.80 M(-43.1%) |
| Sep 2019 | - | $11.96 M(-14.0%) |
| Jun 2019 | - | $13.90 M(-31.7%) |
| Mar 2019 | - | $20.35 M(-3325.2%) |
| Dec 2018 | -$631.00 K(-103.3%) | -$631.00 K(-122.6%) |
| Sep 2018 | - | $2.79 M(-44.3%) |
| Jun 2018 | - | $5.02 M(-46.4%) |
| Mar 2018 | - | $9.35 M(-51.7%) |
| Dec 2017 | $19.38 M(-335.0%) | $19.38 M(-19.9%) |
| Sep 2017 | - | $24.19 M(-10.9%) |
| Jun 2017 | - | $27.16 M(-405.0%) |
| Mar 2017 | - | -$8.90 M(+8.0%) |
| Dec 2016 | -$8.25 M(+60.6%) | -$8.25 M |
| Dec 2015 | -$5.13 M | - |
FAQ
- What is Avenue Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Avenue Therapeutics?
- What is Avenue Therapeutics annual shareholders equity year-on-year change?
- What is Avenue Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly shareholders equity year-on-year change?
What is Avenue Therapeutics annual stockholders equity?
The current annual shareholders equity of ATXI is $1.58 M
What is the all time high annual shareholders equity for Avenue Therapeutics?
Avenue Therapeutics all-time high annual stockholders equity is $19.38 M
What is Avenue Therapeutics annual shareholders equity year-on-year change?
Over the past year, ATXI annual stockholders equity has changed by -$2.32 M (-59.49%)
What is Avenue Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ATXI is $2.61 M
What is the all time high quarterly shareholders equity for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly stockholders equity is $27.16 M
What is Avenue Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ATXI quarterly stockholders equity has changed by +$1.03 M (+64.98%)